Page last updated: 2024-11-02

oxidopamine and Cardiomyopathies

oxidopamine has been researched along with Cardiomyopathies in 1 studies

Oxidopamine: A neurotransmitter analogue that depletes noradrenergic stores in nerve endings and induces a reduction of dopamine levels in the brain. Its mechanism of action is related to the production of cytolytic free-radicals.
oxidopamine : A benzenetriol that is phenethylamine in which the hydrogens at positions 2, 4, and 5 on the phenyl ring are replaced by hydroxy groups. It occurs naturally in human urine, but is also produced as a metabolite of the drug DOPA (used for the treatment of Parkinson's disease).

Cardiomyopathies: A group of diseases in which the dominant feature is the involvement of the CARDIAC MUSCLE itself. Cardiomyopathies are classified according to their predominant pathophysiological features (DILATED CARDIOMYOPATHY; HYPERTROPHIC CARDIOMYOPATHY; RESTRICTIVE CARDIOMYOPATHY) or their etiological/pathological factors (CARDIOMYOPATHY, ALCOHOLIC; ENDOCARDIAL FIBROELASTOSIS).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lurie, KG1
Bristow, MR1
Minobe, WA1
Masek, M1
Billingham, ME1

Other Studies

1 other study available for oxidopamine and Cardiomyopathies

ArticleYear
6-Hydroxydopamine mediated cardiotoxicity in rabbits.
    The American journal of cardiovascular pathology, 1988, Volume: 2, Issue:2

    Topics: Adenylyl Cyclases; Animals; Cardiomyopathies; Dihydroalprenolol; Female; Heart; Hydroxydopamines; My

1988